West Lafayette Newswire

West Lafayette Newswire

Comprehensive Real-Time News Feed for West Lafayette, IN.

Results 1 - 6 of 6 for "u:biospace.com" in West Lafayette, IN

  1. Endocyte Reports First Quarter Financial Results And Provides Clinical And Pipeline UpdateRead the original story

    May 9, 2017 | BioSpace

    WEST LAFAYETTE, Ind., May 10, 2017 -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced financial results for the first quarter ending March 31, 2017, and provided a clinical and pipeline update. "We look forward to providing safety and efficacy updates for our clinical trials of both EC1169 and EC1456 at the Annual Meeting of the American Society of Clinical Oncology next month," said Mike Sherman, president and CEO at Endocyte.

    Comment?

  2. Cook Medical Announces As President Of Cook Biotech IncorporatedRead the original story

    Mar 12, 2017 | BioSpace

    Cook Medical is pleased to announce the promotion of Umesh Patel to president of Cook Biotech Incorporated. As president, Patel will oversee the various functions at Cook Biotech located in West Lafayette, Ind.

    Comment?

  3. Endocyte Reports Fourth Quarter And Year End 2016 Financial Results...Read the original story

    Mar 12, 2017 | BioSpace

    WEST LAFAYETTE, Ind., March 10, 2017 -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced financial results for the fourth quarter ending December 31, 2016, and provided a clinical and business update. "We are pleased to report progress on several aspects of the business during the last several weeks," commented Mike Sherman, president and CEO at Endocyte.

    Comment?

  4. Xynomic In-Licenses Second Oncology Drug Candidate In $60 Million DealRead the original story

    Mar 7, 2017 | BioSpace

    Xynomic Pharma, a US-China oncology startup, has acquired Greater China rights to a novel ACAT-1 inhibitor for cancer indications from Resarci Therapeutics of West Lafayette, Indiana. It will be tested as a treatment for prostate, pancreatic and other solid tumors.

    Comment?

  5. Endocyte Reports Third Quarter 2016 Financial ResultsRead the original story

    Nov 9, 2016 | BioSpace

    WEST LAFAYETTE, Ind., Nov. 09, 2016 -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced financial results for the third quarter ending September 30, 2016, and provided a clinical and business update. "Our clinical pipeline made critical progress during the quarter as we have moved both lead SMDC product candidates, EC1456 and EC1169, into the expansion phases of their trials, and confirmed the maximum clinical doses for each," commented Mike Sherman, president and CEO at Endocyte.

    Comment?

  6. Phytoption Aims To Solve Solubility Problems In Drugs And FoodRead the original story

    Oct 4, 2016 | BioSpace

    Most people don't think about how well an ingredient dissolves in a drug or a nutritional supplement but to the companies that make these products it can be a big problem. If an active ingredient or nutrient dissolves poorly into the product, much of it literally ends up flushed down the toilet.

    Comment?

West Lafayette Job Listings
View or post West Lafayette job listings on Topix.
West Lafayette Real Estate
News, listings, and foreclosures in West Lafayette from Topix.
West Lafayette Mortgages
Find mortgage rates in West Lafayette on Topix.